Self-Reported Adherence to Capecitabine on XELOX Treatment as Adjuvant Therapy for Colorectal Cancer

Adherence has become an important issue in modern oncology treatment. Most studies have included heterogeneous target tumor types, regimens, and therapy settings. Our study focused on capecitabine during capecitabine plus oxaliplatin (XELOX) treatment as an adjuvant therapy for colorectal cancer. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawakami, Kazuyoshi, Yokokawa, Takashi, Kobayashi, Kazuo, Sugisaki, Takahito, Suzuki, Kenichi, Suenaga, Mitsukuni, Yamaguchi, Kensei, Inoue, Ayaka, Machida, Yoshiaki, Yamaguchi, Toshiharu, Hama, Toshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841266/
https://www.ncbi.nlm.nih.gov/pubmed/28766482
http://dx.doi.org/10.3727/096504017X15012905098071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841266/
https://www.ncbi.nlm.nih.gov/pubmed/28766482
http://dx.doi.org/10.3727/096504017X15012905098071

Ejemplares similares